Subscribe to our RSS feeds RSS    
 

 Prostate Cancer Articles

HIFU Effective for Long-Term Prostate Cancer Control

Jody A. Charnow June 03, 2008

High-intensity focused ultrasound (HIFU), a minimally invasive treatment for localized prostate cancer, achieves effective long-term disease control in patients with low- and intermediate-risk tumors, according to researchers in France and Germany.
 

EBRT for Prostate Cancer Hikes Risk of Secondary Cancers

Jody A. Charnow May 23, 2008

ORLANDO, Fla.—External beam radiation therapy (EBRT) increases the risk of secondary malignancies relative to radical prostatectomy in men with localized prostate cancer, data show.
 

Prostate Tumor Biology Differs By Race: Study

John Schieszer May 16, 2008

SAN DIEGO - Genetic analyses suggest that prostate cancer is distinctly different in African-American men compared with European-American men, according to researchers at the National Cancer Institute (NCI) in Bethesda, Md.
 

Sextant Biopsy Alone May Miss Tumors

Jody A. Charnow May 06, 2008

PROSTATE BIOPSIES in men with a PSA level of 4.01-10.0 ng/mL and normal findings on digital rectal examination (DRE) should include lateral cores in addition to the sextant biopsy, according to investigators.
 

NSAIDs Lower PCa Death Risk

Jody A. Charnow May 06, 2008

SAN FRANCISCO—High exposure to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is asso-ciated with decreased prostate cancer-specific mortality, according to study findings presented here at the 2008 Genitourinary Cancers Symposium.
 

Lower PSAV Threshold Useful

Jody A. Charnow May 06, 2008

SAN FRANCISCO—A PSA velocity (PSAV) threshold of 0.4 ng/mL per year can distinguish between clinically significant and insignificant prostate cancer, new data suggest.
 

Untreated PCa Seldom Fatal in Elderly

Jody A. Charnow May 06, 2008

SAN FRANCISCO—Few elderly men with localized prostate cancer will die from the malignancy after 10 years even in treatment is delayed, so active surveillance for these patients may be a reasonable option, according to researchers.
 

Study: Combo Promising for Metastatic AIPC

Jody A. Charnow May 06, 2008

SAN FRANCISCO—Adding thalidomide and bevacizumab to docetaxel may hold promise for treating patients with metastatic androgen-independent prostate cancer (AIPC), investigators report.
 

Repeat PSA Tests May Aid Prostate Biopsy Decisions

Jody A. Charnow May 06, 2008

Following an initial PSA test result of 3.0-19.99 ng/mL in men aged 50-70 years, a repeat PSA test within seven weeks allows for more accurate assessment as to whether a biopsy will reveal prostate cancer, a British team reports.
 

PCa Chemotherapy Holidays Possible

John Schieszer May 06, 2008

INTERMITTENT chemotherapy may be an option for some men with androgen-independent prostate cancer (AIPC), researchers found.
 
 
A Haymarket Media, Inc website
Home | News | Departments | Editorial Board | Contact | Subscribe | Advertise | About
From Haymarket Medical the Publishers of:
Monthly Prescribing Reference Nurse Practitioners' Prescribing Reference Physician Assistants' Prescribing Reference
Cortlandt Forum McKnight's Long-Term Care News Renal & Urology News The Clinical Advisor JAAPA McKnight's Assisted Living